Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
04/15/2008
Trade Name:
Patanase Nasal Spray
Generic or Proper Name (*):
olopatadine hydrochloride
Indications Studied:
Relief of symptoms of seasonal allergic rhinitis (SAR) in patients 12 years of age and older
Therapeutic Category:
Antihistamine
Ages Studied:
12 years and older
Study #:
8
Study Type:
Efficacy/Safety/Pharmacokinetic
Study Design:
Single-Blind/Parallel Group/Traditional Pharmacokinetic
No Patients:
271
No Centers:
7
No Countries:
1
BPCA(B), PREA(P):
P
-
-